Polymorphisms in HPV E6/E7 protein interacted genes and risk of cervical cancer in Chinese women: A case-control analysis

详细信息    查看全文

• 作者：Xiaoyi Zhou ; Suping Han ; Sumin Wang ; Xiaojun Chen ; Jing Dong ; Xiaoyan Shi ; Yankai Xia ; Xinru Wang ; Zhibin Hu ; Hongbing Shen
• 关键词：BRCA1 ; BARD1 ; TP53 ; Polymorphism ; Cervical cancer
• 刊名：Gynecologic Oncology
• 出版年：2009
• 出版时间：August 2009
• 年：2009
• 卷：114
• 期：2
• 页码：327-331
• 全文大小：155 K

文摘

Objective

Accumulating studies indicate that HPV E6/E7 oncoproteins interacting genes, TP53, BRCA1 and BARD1, play a critical role in cervical carcinogenesis. We hypothesized that potentially functional polymorphisms in TP53, BRCA1 and BRAD1 may individually and/or jointly contribute to cervical cancer risk.

Methods

We genotyped 4 single nucleotide polymorphisms (SNPs) with amino acid changes, TP53 Pro72Arg (rs1042522), BRCA1 Pro871Leu (rs799917), BARD1 Pro24Ser (rs1048108) and Arg378Ser (rs2229571), in a case-control study of 404 cervical cancer cases and 404 cancer-free controls in Chinese women.

Results

Logistic regression analysis showed that the BRCA1 variant rs799917 TT genotype was associated with a significantly decreased risk of cervical cancer in a recessive genetic model (adjusted OR = 0.62, 95 % CI = 0.40–0.95), compared with the genotypes CT/CC. However, no significant associations with cervical cancer were observed for other 3 SNPs (adjusted OR = 1.01, 95 % CI = 0.68–1.50 for rs1048108 TT vs CT/CC; adjusted OR = 1.04, 95 % CI = 0.67–1.64 for rs2229571 CC vs GG/GC; adjusted OR = 0.84, 95 % CI = 0.59–1.20 for rs1042522 CC vs GG/GC).

Conclusion

These findings indicate that BRCA1 rs799917 polymorphism may contribute to the risk of cervical cancer in this Chinese population, and further validation in other populations are warranted.